Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health (NYSE:HIMS).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner ...

Hims & Hers Health Inc (NYSE:HIMS) shares are up 3.4% to trade at $30.60 at last glance. The equity has struggled of late, now carrying a 47.3% nine-month deficit after last week gapping to its lowest level since late April. Meanwhile, overhead pressure at the 20-day moving average has been guiding the stock lower since December, and capped a rally earlier this month.The telehealth company, which is popular for weight-loss drug prescriptions, has also appeared on Senior Quantitative Analyst Rocky White's li ...

Key Takeaways Hims & Hers is scaling its digital platform with new specialties and integrated lab diagnostics.HIMS' platform learns from patient data to offer proactive, personalized treatment pathways.AI, data infrastructure and in-house manufacturing bolster Hims & Hers' ability to deliver care at scale.The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS) , operates at the intersection of healthcare and proprietary technology by positioning its digital platform as the core engine of ...

Core Insights - Hims & Hers Health (HIMS) has experienced a significant 40% drawdown since the last coverage, indicating potential underlying issues within the company [1] Company Overview - Hims & Hers Health operates in the consumer health sector, which is characterized by emotional trading patterns [1] Investment Strategy - The investment approach focuses on identifying high-potential winners before they break out, emphasizing asymmetric opportunities with an upside potential of 3-5 times the downside risk [1] - The strategy leverages market inefficiencies and contrarian insights to maximize long-term compounding while safeguarding against capital impairment [1] - A strong margin of safety is prioritized to protect against capital impairment while aiming for outsized returns over a 2-3 year investment horizon [1]

Core Insights - Hims & Hers Health (HIMS) has experienced a significant 40% drawdown since the last coverage, indicating potential underlying issues within the company [1] Company Overview - Hims & Hers Health operates in the consumer health sector, which is characterized by emotional trading patterns [1] Investment Strategy - The investment approach focuses on identifying high-potential winners before they break out, emphasizing asymmetric opportunities with an upside potential of 3-5 times the downside risk [1] - The strategy leverages market inefficiencies and contrarian insights to maximize long-term compounding while safeguarding against capital impairment [1] - A strong margin of safety is prioritized to protect against capital impairment, with a 2-3 year investment horizon to endure market volatility [1]

Key Takeaways HIMS offers consumer-focused care with expanding services in weight, hormone and preventive health.TEM leverages a growing multimodal dataset to power diagnostics and AI-driven clinical decision tools.HIMS expands into lab testing and diagnostics to support long-term, proactive health management.Digital healthcare platforms are expanding across both consumer wellness and precision medicine, with Hims & Hers Health, Inc. (HIMS) and Tempus AI, Inc. (TEM) operating in distinct segments of the mar ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

Core Insights - Hims & Hers Health, Inc. (HIMS) has developed a scalable, software-driven platform that enhances its capabilities as usage increases, connecting consumers, licensed providers, fulfillment, and diagnostics into a unified system [1][7] - The company is expanding its service offerings, including weight loss and menopause care, through a digital workflow that integrates at-home testing and provider support, positioning data as central to proactive health management [2][7] - Hims & Hers is investing in AI and data infrastructure to strengthen its platform while pursuing international expansion, indicating a growth strategy focused on technology rather than physical presence [3][7] Financial Performance - Hims & Hers shares have increased by 12.7% over the past year, contrasting with a 2.7% decline in the industry [6] - The Zacks Consensus Estimate predicts a 77.8% increase in earnings per share for HIMS in 2025 compared to 2024 [8] - HIMS has a forward 12-month price-to-sales ratio of 2.6X, which is lower than the industry average of 4.7X and its three-year median of 2.7X [10] Earnings Estimates - The current quarter's earnings estimate for HIMS is $0.04, with projections of $0.14 for the next quarter and $0.48 for the current year [11] - The earnings growth estimates indicate a year-over-year decline of 63.64% for the current quarter, but a projected growth of 77.78% for the next year [11]

Core Insights - The analysis of Hims & Hers Health, Inc. (HIMS) emphasizes the company's founding story, its founders, and the long-term growth prospects outlined by management, highlighting their ambitions for future expansion [1] Group 1: Company Overview - Hims & Hers Health, Inc. is focused on uncovering mispriced assets that the market has overlooked, with a fundamentals-first approach guiding their investment strategy [1] Group 2: Market Perspective - The company operates in an algorithm-driven investment environment where sentiment and technicals often take precedence over fundamentals, yet it remains committed to a fundamentals-first approach [1]